Clinical Trial Update: A Study of a New Asthma Medicine in Asthmatics Whose Asthma Worsens With Exercise [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating a new asthma medicine for patients whose asthma worsens with exercise has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 3 | Status: WITHDRAWN